Replies to post #327535 on NorthWest Biotherapeutics Inc (NWBO)

[spartex]

5.) I’m guessing it’s some rule, but I noticed that she actively avoided saying the name of the company.

She's probably trying to maintain a neutral position and not acknowledge a pending Phase 3 trial results while she is still providing summary of the research she has done for the effectiveness of DCVax-L. Strictly avoiding any hint of promoting NWBO in any way possible (imo).

[hankmanhub]

6.) I saw the 47% 3yr number, but that wasn’t the new data. That was something we’ve seen before, and I’m not sure what it was referring to.

The 47% number is on slide #11, but it comes from old data from Prins in 2011 as shown on the slide.